Сравнение

Sincalide vs. Terlipressin

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

25126-32-3

14636-12-5

Молекулярная масса

1143.29 g/mol

1227.37 g/mol

Период полувыведения

нет данных

Последовательность

Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2

нет данных

Механизм действия

Sincalide

Sincalide activates CCK receptors, triggering gallbladder contraction and pancreatic enzyme secretion. This effect is used diagnostically to measure the gallbladder ejection fraction (e.g. in HIDA scintigraphy).

Terlipressin

Terlipressin is slowly converted in the body to lysine-vasopressin by cleavage of the three N-terminal glycyl residues (reservoir effect) and activates V1 receptors. The splanchnic vasoconstriction improves renal perfusion in hepatorenal syndrome.

Доказательная база

Наивысшая доказательность

Исследование на людях

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Sincalide	Terlipressin
Германия	Неясно	Рецептурный
США	Рецептурный	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Sincalide and Terlipressin?: Sincalide is classified as "Исследования (прочее)", while Terlipressin is classified as "Исследования (прочее)". Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Sincalide or Terlipressin?: The highest available evidence level is "Исследование на людях" for Sincalide and "РКИ на людях" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Sincalide and Terlipressin in Germany and the United States?: Германия: Sincalide — Неясно, Terlipressin — Рецептурный. США: Sincalide — Рецептурный, Terlipressin — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Sincalide

Terlipressin

Германия

Неясно

Рецептурный

США

Рецептурный

Frequently asked questions

What is the difference between Sincalide and Terlipressin?

Sincalide is classified as "Исследования (прочее)", while Terlipressin is classified as "Исследования (прочее)". Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Sincalide or Terlipressin?

The highest available evidence level is "Исследование на людях" for Sincalide and "РКИ на людях" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Sincalide and Terlipressin in Germany and the United States?

Германия: Sincalide — Неясно, Terlipressin — Рецептурный. США: Sincalide — Рецептурный, Terlipressin — Рецептурный. These are factual summaries with source and review date on the individual pages.